|
Mar 18
|
Optimism around Hikma Pharmaceuticals (LON:HIK) delivering new earnings growth may be shrinking as stock declines 3.3% this past week
|
|
Jan 8
|
Guardant Health and Hikma Partner to Offer Cancer Screening and Comprehensive Genomic Profiling Tests in the Middle East and North Africa
|
|
Aug 22
|
Marks & Spencer Set for FTSE 100 Comeback After This Year’s 78% Share Price Rise
|
|
Aug 22
|
Are Strong Financial Prospects The Force That Is Driving The Momentum In Hikma Pharmaceuticals PLC's LON:HIK) Stock?
|